Soleno Therapeutics Inc (SLNO) — Cash Flow Quality Index
Soleno Therapeutics Inc (SLNO) has a Cash Flow Quality Index of 0.83x as of March 2026. Operating cash flow of $25.98 Million is below net income of $31.38 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Soleno Therapeutics Inc (SLNO) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Soleno Therapeutics Inc Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Soleno Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Soleno Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Soleno Therapeutics Inc (2025–2025)
Year-by-year earnings quality comparison for Soleno Therapeutics Inc. For live market cap and the full company financial profile, see Soleno Therapeutics Inc market cap and net worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | $46.80 Million | $20.89 Million | — |